DECISION SUPPORT SYSTEM (DSS) FOR MOLECULAR RADIOTHERAPY BASED ON DIGITAL PATIENTS (Q2035310)

From EU Knowledge Graph
Revision as of 08:41, 2 November 2020 by DG Regio (talk | contribs) (‎Removed claim: financed by (P890): Directorate-General for Regional and Urban Policy (Q8361), Removing unnecessary financed by statement)
Jump to navigation Jump to search
Project Q2035310 in Italy
Language Label Description Also known as
English
DECISION SUPPORT SYSTEM (DSS) FOR MOLECULAR RADIOTHERAPY BASED ON DIGITAL PATIENTS
Project Q2035310 in Italy

    Statements

    0 references
    183,393.18 Euro
    0 references
    366,786.35 Euro
    0 references
    50.0 percent
    0 references
    13 December 2016
    0 references
    6 July 2019
    0 references
    UNIVERSITA' DEGLI STUDI DI ROMA LA SAPIENZA
    0 references
    KAY SYSTEMS ITALIA SRL
    0 references
    0 references
    0 references
    0 references

    41°53'35.95"N, 12°28'58.55"E
    0 references
    LA RADIOTERAPIA MOLECOLARE, INDICATA IN MOLTE NEOPLASIE, IMPIEGA RADIONUCLIDI COME SORGENTI NON SIGILLATE (SPESSO RADIOFARMACI) PER RILASCIARE RADIAZIONI E DISTRUGGERE CELLULE NEOPLASTICHE. (Italian)
    0 references
    THE MOLECULAR RADIOTHERAPY, REFERRED TO IN MANY CANCERS, USES RADIONUCLIDES AS NON-SEALED SOURCES (OFTEN RADIOPHARMACEUTICALS) TO RELEASE RADIATION AND DESTROY NEOPLASTIC CELLS. (English)
    0 references

    Identifiers

    F87H18000440007
    0 references